Literature DB >> 1775201

Use of ion channel blockers in studying the regulation of skeletal muscle contractions.

S Y Lin-Shiau1, S Y Day, W M Fu.   

Abstract

Effects of K(+)- and Cl(-)-channel blockers on the muscle contraction of mouse diaphragm in response to direct electrical muscle stimulation were studied. K(+)-channel blockers (0.1-1 mmol/l 4-aminopyridine, 0.4-1.2 mmol/l uranyl nitrate and 2-30 mmol/l tetraethylammonium chloride) and a Cl(-)-channel blocker (0.01-0.03 mmol/l 9-anthracene carboxylic acid) increased the contractile amplitudes in a limited extent not to exceed over 50% of control. However, the sequential applications of two different channel blockers at a rather low concentration markedly increased the contractile responses mostly over 300% of control except the combination of 4-aminopyridine and uranyl nitrate. It appears that two K(+)-channel blockers synergistically exerted their effects rather than additionally in the regulation of muscle contractions. Investigation on the possible mechanism of the synergistic action of K(+)-channel blockers suggested that prolongation of action potential durations was in a linear correlation with the increased contractions. On the other hand, the contractile potentiation induced by combination of K(+)- and Cl(-)-channel blockers was attributed to the production of repetitive action potential firings (150 +/- 12 Hz) upon a single electrical stimulation. Similar to Cl(-)-channel blocker, low Cl- as well as low Ca2+ enhanced K(+)-channel blockers in producing contractile potentiation accompanied with stimulus-bound repetitive discharges. Tetrodotoxin at a concentration of 0.03 mumol/l which did not affect the twitches evoked by electrical stimulations completely inhibited the contractile potentiation induced by the combined application of K(+)- and Cl(-)-channel blockers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775201     DOI: 10.1007/bf00174753

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  39 in total

1.  The action of Ca2+ , Mg2+ and H+ on the contraction threshold of frog skeletal muscle: Evidence for surface charges controlling electro-mechanical coupling.

Authors:  M Dörrscheidt-Käfer
Journal:  Pflugers Arch       Date:  1976-03-11       Impact factor: 3.657

2.  An analysis of the end-plate potential recorded with an intracellular electrode.

Authors:  P FATT; B KATZ
Journal:  J Physiol       Date:  1951-11-28       Impact factor: 5.182

3.  Action potentials reconstructed in normal and myotonic muscle fibres.

Authors:  R H Adrian; M W Marshall
Journal:  J Physiol       Date:  1976-06       Impact factor: 5.182

4.  Effects of 4-aminopyridine at the frog neuromuscular junction.

Authors:  J Molgo; M Lemeignan; P Lechat
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

5.  Role of the action potential in excitation-contraction coupling.

Authors:  A Sandow; S R Taylor; H Preiser
Journal:  Fed Proc       Date:  1965 Sep-Oct

Review 6.  Tetraethylammonium ions and the potassium permeability of excitable cells.

Authors:  P R Stanfield
Journal:  Rev Physiol Biochem Pharmacol       Date:  1983       Impact factor: 5.545

7.  The effect of calcium on the mechanical response of single twitch muscle fibres of Xenopus laevis.

Authors:  B Frankenhaeuser; J Lännergren
Journal:  Acta Physiol Scand       Date:  1967-03

8.  Intracellular chloride and the mechanism for its accumulation in rat lumbrical muscle.

Authors:  C C Aickin; W J Betz; G L Harris
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

9.  Myotonia. An evaluation of the chloride hypothesis.

Authors:  R L Barchi
Journal:  Arch Neurol       Date:  1975-03

10.  Chloride conductance in normal and myotonic muscle fibres and the action of monocarboxylic aromatic acids.

Authors:  S H Bryant; A Morales-Aguilera
Journal:  J Physiol       Date:  1971-12       Impact factor: 5.182

View more
  6 in total

1.  Role of K+ channels in L-6 myoblast migration.

Authors:  Erik van Lunteren; Christopher Sankey; Michelle Moyer; Rudolf M Snajdar
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

2.  Symptomatic treatment of botulism with a clinically approved small molecule.

Authors:  Edwin Vazquez-Cintron; James Machamer; Celinia Ondeck; Kathleen Pagarigan; Brittany Winner; Paige Bodner; Kyle Kelly; M Ross Pennington; Patrick McNutt
Journal:  JCI Insight       Date:  2020-01-30

3.  Use of ion channel blockers in the exploration of possible mechanisms involved in the myopathy of diabetic mice.

Authors:  S Y Lin-Shiau; S H Liu; M J Lin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

4.  Improvement of diaphragm and limb muscle isotonic contractile performance by K+ channel blockade.

Authors:  Erik van Lunteren; Jennifer Pollarine
Journal:  J Neuroeng Rehabil       Date:  2010-01-11       Impact factor: 4.262

5.  The Effects of K(+) Channel Blockade on Eccentric and Isotonic Twitch and Fatiguing Contractions in situ.

Authors:  Erik van Lunteren; Michelle Moyer
Journal:  Front Physiol       Date:  2012-09-28       Impact factor: 4.566

6.  Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A.

Authors:  Phillip H Beske; Katie M Hoffman; James B Machamer; Margaret R Eisen; Patrick M McNutt
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.